4//SEC Filing
Quinn Deborah 4
Accession 0001600132-18-000017
CIK 0001600132other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:42 PM ET
Size
6.7 KB
Accession
0001600132-18-000017
Insider Transaction Report
Form 4
Quinn Deborah
Chief Medical Officer
Transactions
- Award
Common Stock
2018-01-12+29,557→ 104,611 total - Award
Stock Option (right to buy)
2018-01-12+100,000→ 100,000 totalExercise: $2.03Exp: 2028-01-12→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 12, 2018. This option vests in quarterly installments over a four-year period from the date of grant.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeother
Related Parties
1- filerCIK 0001656606
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 4:42 PM ET
- Size
- 6.7 KB